1. United States Stocks

  2. •

    Health technology

  3. •

    Biotechnology
First Tracks Biotherapeutics, Inc.

First Tracks Biotherapeutics, Inc.

800.00
MXN
- -
- -
-16.66EPS
Dec 02Next Earn

Important Dates

First Tracks Biotherapeutics Inc's next confirmed earnings release is scheduled for December 2, 2026.

Earnings Date12/2/2026

Share Statistics

As of June 30, 2026, First Tracks Biotherapeutics Inc has 35.39M shares outstanding.

Shares Outstanding35.39M

Financial Position

As of June 30, 2026, First Tracks Biotherapeutics Inc maintains a current ratio of 14.28, meaning it holds 14.3x the short-term assets needed to cover near-term liabilities.

Current Ratio14.28
Quick Ratio13.91
Debt / Equity2.57

Income Statement

MXN

These figures cover the twelve months ended June 30, 2026.

Pretax Income-583.10M

Balance Sheet

MXN

As of June 30, 2026, First Tracks Biotherapeutics Inc holds 2.94B in cash and equivalents against 75.70M in total debt, resulting in a net debt position of -2.94B. Total book value stands at 2.95B, with working capital of 2.89B providing operational flexibility.

Cash & Cash Equivalents2.94B
Total Debt75.70M
Net Debt-2.94B
Equity (Book Value)2.95B
Book Value Per Share83.33
Working Capital2.89B

Cash Flow

MXN

These figures cover the twelve months ended June 30, 2026. After subtracting -436,790.00 in capital expenditures, free cash flow totaled -558.10M - equivalent to -15.94 per share.

Capital Expenditures-436,790.00
Free Cash Flow-558.10M
FCF Per Share-15.94